Human TCL1A Ready-To-Use IHC Kit Size:50 Test CD63 expression can be used

CD63 expression can be used to predict prognosis in early-stage carcinomas and is identical to the melanoma-associated antigen ME491 and the platelet antigen PTLGP40

Human IRF4 Ready-To-Use IHC Kit

Human RPS20 Ready-To-Use IHC Kit

Chromogranin A precursor

The isoform encoded by the unspliced mRNA

Human TCL1A Ready-To-Use IHC Kit Size:50 Test CD63 expression can be usedHuman TCL1A Ready To Use IHC Kit Cat. No.: IHC0584H Sample Type: FFPE tissue Size: 50T (including a control slide) Storage and Stability: Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. Background Overexpression of the TCL1 gene in humans has been implicated in the development of mature T cell leukemia, in which chromosomal rearrangements bring the TCL1 gene